Very interesting comment you made as to the time other competitors application for treatment takes,it sounds like you have some experience in the medical game. A lot of posts keep blustering on about Perry’s management and the share price.What they should be watching is the time savings made in both the operating theatre and recovery wards, which come at huge costs. AVH declared these savings in time to be about 30% making for insurance companies who have to pay out the costs rather large reduction in there payments. For the low income people there is no costs as the Govt now foot the bill through the recent reimbursements issued for recall. To get those savings I would think those insurance companies would be putting a lot of pressure on hospitals to change their ways. And if you look at what is coming is even bigger revenue earnings for other applications. I find the recent successful delivery of telomerase into skin cells ( animals to date) for skin rejuvenation the big one but it will take time.
AVH Price at posting:
$3.40 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)